A team of researchers from Spain found a potential new avenue for treating early-stage Huntington's disease.
The study was published in BMC Medical Genomics.
The researchers' long-term goal is to be able to use the research results to develop a treatment for Huntington's disease using glial cells.
The mechanism could reduce the toxic aggregation of huntingtin protein in the long run.